-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Blood Buddies: Adult Clinical Malignant Hematology

Symposia: ASH-a-Palooza Program: Trainee Activities and Services
Hematology Disease Topics & Pathways:
Research, Clinical Research, Diseases, Lymphoid Malignancies, Myeloid Malignancies
Friday, December 6, 2024: 1:30 PM-3:50 PM
Café Sevilla Restaurant (Gaslamp Quarter)
Panelists:
Alison R. Walker, MD, MBA, MPH, H. Lee Moffitt Cancer Center and Research Institute , Aaron T. Gerds, MD, MS, Cleveland Clinic Taussig Cancer Institute , Jia Ruan, MD, PhD, The New York and Presbyterian Hospital , Jennifer Amengual, MD, NYU Medical Center , Oreofe O. Odejide, MD, Dana-Farber Cancer Institute , Janis L. Abkowitz, MD, University of Washington , Monique A. Hartley-Brown, MD, DFCI , Swapna Thota, MD, University of Tennessee Health Science Center , Adam Scott Kittai, MD, The Ohio State University , Kerry J. Savage, MD, MSc, BC Cancer , Greeballa Magzoub, Oklahoma University Health Sciences Center and Olatoyosi Odenike, MD, University of Chicago
Disclosures:
Gerds: AbbVie: Consultancy; GSK: Consultancy; Rain Oncology: Consultancy; PharmaEssentia: Consultancy; Agios: Consultancy; Disc Medicine: Consultancy; BMS: Consultancy. Ruan: BMS: Honoraria, Research Funding; Genentech: Research Funding; Janssen: Honoraria; AstraZeneca: Honoraria, Research Funding. Abkowitz: Disc Medicine: Consultancy, Research Funding. Hartley-Brown: Sanofi: Consultancy, Honoraria, Research Funding; GSK: Consultancy, Honoraria, Research Funding; AbbVie: Consultancy, Honoraria, Research Funding; Janssen: Consultancy, Honoraria, Research Funding; Bristol Myers Squibb/Celgene: Consultancy, Honoraria, Research Funding; Karyopharm: Consultancy, Honoraria, Research Funding; Multiple Myeloma Research Foundation: Consultancy, Honoraria, Research Funding; Cancer Care: Consultancy, Honoraria. Thota: Sobi Inc, Novartis, Alexion, pharmaessentia: Membership on an entity's Board of Directors or advisory committees. Kittai: BeiGene: Consultancy, Research Funding, Speakers Bureau; Janssen: Consultancy; Abbvie: Consultancy, Honoraria; AstraZeneca Pharmaceuticals LP.: Consultancy, Honoraria, Research Funding; KITE: Consultancy; Eli Lilly: Consultancy, Honoraria; Bristol-Myers Squibb: Consultancy. Savage: Seagen: Consultancy, Honoraria, Research Funding; AbbVie: Consultancy; Regeneron: Other: DSMC; Bristol Myers Squibb: Consultancy, Research Funding. Odenike: AbbVie (Inst); Agios (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CTI BioPharma Corp (Inst); Daiichi Sankyo (Inst); Incyte (Inst); Janssen Oncology (Inst); Kartos Therapeutics (Ins: Research Funding; AbbVie; Blueprint Medicines; BMS; Bristol-Myers Squibb/Celgene (Inst); Celgene; CTI; Impact Biomedicines; Kymera; Novartis; SERVIER; Taiho Pharmaceutical; Treadwell Therapeutics: Honoraria.
Trainees have the opportunity to meet with leaders in the field. Trainees sign up for a one-on-one Blood Buddy ten-minute mentoring session with a faculty member. Blood Buddies are experts in various hematology topic areas. This is an excellent opportunity for trainees to network with and receive mentorship from seasoned faculty. There are 3 Blood Buddies sessions at the event and 3 ten-minute rounds within each session. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Buddies. The featured topics are: Adult Clinical Malignant Hematology; Pediatric Clinical Malignant Hematology; Adult Clinical Classical Hematology; Pediatric Clinical Classical Hematology; BMT Pediatric and Adult; Quality Improvement; Medical Education; PhD/Laboratory; Diversity, Equity, and Inclusion; International Medical Graduates; Future of Hematology (Artificial Intelligence); Industry Career Pathway; Federal Career Pathway.